High Expression of Long Non-coding RNA SPRY4-IT1 Predicts Poor Prognosis of Clear Cell Renal Cell Carcinoma

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2014 Oct 23

PMID 25337221

Citations 57

Authors

Hai-Min Zhang

Feng-Qiang Yang

Yang Yan

Jian-Ping Che

Jun-Hua Zheng

Affiliations

Soon will be listed here.

Abstract

Introduction: Long non-coding RNAs (lncRNAs) play a key role in cellular processes, such as cell growth, apoptosis, and carcinogenesis. lncRNAs SPRY4-IT1 has recently been identified to be involved in tumorigenesis of several cancers such as non-small cell lung cancer and esophageal squamous cell carcinoma. However, the role of SPRY4-IT1 in clear cell renal cell carcinoma (ccRCC) remains unclear.

Methods: The expression of SPRY4-IT1 was examined in ccRCC patients and renal cancer cell lines by using quantitative real-time PCR (qRT-PCR). The relationship between SPRY4-IT1 level and clinicopathological parameters of ccRCC was analyzed with the Kaplan-Meier method and Cox proportional hazards model. Small interfering RNA (siRNA) was used to suppress SPRY4-IT1 expression in renal cancer cell line 786-O. In vitro assays were performed to further explore its role in renal cancer progressio.

Results: The relative level of SPRY4-IT1 was significantly higher in ccRCC tissues compared to the adjacent normal renal tissues. And higher expression of SPRY4-IT1 was found in renal cancer cell lines compared with the normal human proximal tubule epithelial cell line HK-2. The ccRCC patients with higher SPRY4-IT1 expression had an advanced clinical stage and poorer prognosis than those with lower SPRY4-IT1 expression. Multivariate analyses by Cox's proportional hazard model revealed that expression of SPRY4-IT1 was an independent prognostic factor in ccRCC. In vitro assays, our results indicated that knockdown of SPRY4-IT1 reduced renal cancer cell proliferation, migration, and invasion.

Conclusions: Our data suggested that lncRNA SPRY4-IT1 might be considered as a potential prognostic indicator and a potential target for therapeutic intervention in RC.

Citing Articles

Renal cancer: signaling pathways and advances in targeted therapies.

Jiang A, Li J, He Z, Liu Y, Qiao K, Fang Y MedComm (2020). 2024; 5(8):e676.

PMID: 39092291 PMC: 11292401. DOI: 10.1002/mco2.676.

The Expression Patterns and Implications of , , and in Esophageal Adenocarcinoma.

Syllaios A, Gazouli M, Vailas M, Mylonas K, Sakellariou S, Sougioultzis S Int J Mol Sci. 2024; 25(1).

PMID: 38203269 PMC: 10778904. DOI: 10.3390/ijms25010098.

New insights into fibrotic signaling in renal cell carcinoma.

Chen J, Yiu W, Tang P, Tang S Front Cell Dev Biol. 2023; 11:1056964.

PMID: 36910160 PMC: 9996540. DOI: 10.3389/fcell.2023.1056964.

Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers.

Tortora F, La Civita E, Trivedi P, Febbraio F, Terracciano D, Cimmino A Int J Mol Sci. 2023; 24(5).

PMID: 36902032 PMC: 10003365. DOI: 10.3390/ijms24054601.

Regulatory function of DNA methylation mediated lncRNAs in gastric cancer.

Li N, Zeng A, Wang Q, Chen M, Zhu S, Song L Cancer Cell Int. 2022; 22(1):227.

PMID: 35810299 PMC: 9270757. DOI: 10.1186/s12935-022-02648-1.

References

Huttenhofer A, Schattner P, Polacek N . Non-coding RNAs: hope or hype?. Trends Genet. 2005; 21(5):289-97. DOI: 10.1016/j.tig.2005.03.007. View

Xie H, Wu Q, Zhu B, Chen F, Ji L, Li S . Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol. 2014; 35(8):7743-54. DOI: 10.1007/s13277-014-2013-y. View

Taft R, Pang K, Mercer T, Dinger M, Mattick J . Non-coding RNAs: regulators of disease. J Pathol. 2009; 220(2):126-39. DOI: 10.1002/path.2638. View

Ljungberg B, Cowan N, Hanbury D, Hora M, Kuczyk M, Merseburger A . EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010; 58(3):398-406. DOI: 10.1016/j.eururo.2010.06.032. View

Gibb E, Brown C, Lam W . The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011; 10:38. PMC: 3098824. DOI: 10.1186/1476-4598-10-38. View

Khaitan D, Dinger M, Mazar J, Crawford J, Smith M, Mattick J . The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011; 71(11):3852-62. DOI: 10.1158/0008-5472.CAN-10-4460. View

Esteller M . Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12(12):861-74. DOI: 10.1038/nrg3074. View

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

Escudier B, Eisen T, Porta C, Patard J, Khoo V, Algaba F . Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7:vii65-71. DOI: 10.1093/annonc/mds227. View

10.

Spizzo R, Almeida M, Colombatti A, Calin G . Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene. 2012; 31(43):4577-87. PMC: 3433647. DOI: 10.1038/onc.2011.621. View

11.

Lee S, Vasudevan S . Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol. 2012; 768:97-126. DOI: 10.1007/978-1-4614-5107-5_7. View

12.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

13.

Han Y, Liu Y, Gui Y, Cai Z . Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol. 2012; 107(5):555-9. DOI: 10.1002/jso.23264. View

14.

Janowitz T, Welsh S, Zaki K, Mulders P, Eisen T . Adjuvant therapy in renal cell carcinoma-past, present, and future. Semin Oncol. 2013; 40(4):482-91. PMC: 3765962. DOI: 10.1053/j.seminoncol.2013.05.004. View

15.

Shi X, Sun M, Liu H, Yao Y, Song Y . Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339(2):159-66. DOI: 10.1016/j.canlet.2013.06.013. View

16.

Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F . Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190(6):2278-87. DOI: 10.1016/j.juro.2013.07.001. View

17.

Liu X, Liu Z, Sun M, Liu J, Wang Z, De W . The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013; 13:464. PMC: 3851855. DOI: 10.1186/1471-2407-13-464. View

18.

Yang Q, Deng Y . Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol. 2014; 7(4):1286-92. PMC: 4014209. View

19.

Rini B, Campbell S, Escudier B . Renal cell carcinoma. Lancet. 2009; 373(9669):1119-32. DOI: 10.1016/S0140-6736(09)60229-4. View